The IPO Buzz: Aktis Oncology Prices IPO at $18 – High End – 1st Big IPO of ’26 Pops on NASDAQ

Aktis Oncology (AKTS) priced its recently upsized IPO at $18.00 – the top of its $16.00-to-$18.00 range – and sold 17.65 million shares – the number of shares in the prospectus – to raise $317.7 million on Thursday night, Jan. 8, 2026. The stock of Aktis Oncology jumped in its NASDAQ debut - opening at $27.00 - up 50 percent from its IPO price - at 11:14 a.m. EST on Friday, Jan. 9, 2026. ..

Read more January 8, 2026

IPO Calendar

Company Symbol proposed Lead Managers Shares (Millions) Price Low Price High Est. $ Volume Expected to Trade SCOOP Rating Rating Change
Aktis Oncology AKTS J.P.Morgan/BofA Securities/Leerink Partners/TD Cowen 17.7 18.00 18.00 $ 317.7 mil 1/9/2026 Priced S/O S/O
Atlas Critical Minerals (Uplisting) ATCX A.G.P. (Alliance Global Partners)/Banco Bradesco BBI 1.2 8.00 8.00 $ 9.6 mil 1/9/2026 Priced S/O S/O
Lafayette Digital Acquisition Corp. I ZKPU BTIG 25.0 10.00 10.00 $ 250.0 mil 1/9/2026 Priced S/O S/O
Read more

Last 100 IPOs - January 9, 2026

Number of IPOs priced : 100
Number Up: 63
Number Down: 33
Number Unchanged: 4
Percentage Change From Issue Price: 9.33%
Percentage Change for The Nasdaq Composite 35.22%

2026 IPO Scorecard - January 9, 2026

Number of IPOs priced (Excluding 133 units) : 231
Number Up: 132
Number Down: 88
Number Unchanged: 11
Total Return From Issue Price: 16.98%
The Nasdaq Composite Index YTD % Change 35.22%